ES2043535A1 - Procedure for the obtaining of 1,2,3,9-tetrahydro-9-methyl-3- (2-methyl-1H-imidazol-1-il) methyl-4h-carbazol-4-ona. (Machine-translation by Google Translate, not legally binding) - Google Patents

Procedure for the obtaining of 1,2,3,9-tetrahydro-9-methyl-3- (2-methyl-1H-imidazol-1-il) methyl-4h-carbazol-4-ona. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES2043535A1
ES2043535A1 ES9200552A ES9200552A ES2043535A1 ES 2043535 A1 ES2043535 A1 ES 2043535A1 ES 9200552 A ES9200552 A ES 9200552A ES 9200552 A ES9200552 A ES 9200552A ES 2043535 A1 ES2043535 A1 ES 2043535A1
Authority
ES
Spain
Prior art keywords
methyl
carbazol
imidazol
tetrahydro
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES9200552A
Other languages
Spanish (es)
Other versions
ES2043535B1 (en
Inventor
Clotet Juan Huguet
Ges Jose Maria Caldero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Pharma Iberia SL
Original Assignee
Vita Invest SA
Quimica Sintetica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest SA, Quimica Sintetica SA filed Critical Vita Invest SA
Priority to ES09200552A priority Critical patent/ES2043535B1/en
Priority to SK169-93A priority patent/SK278786B6/en
Priority to GR930100094A priority patent/GR930100094A/en
Priority to EG14493A priority patent/EG20262A/en
Priority to CZ93396A priority patent/CZ281753B6/en
Priority to KR1019930003609A priority patent/KR100277414B1/en
Priority to AR93324474A priority patent/AR248019A1/en
Priority to NO930887A priority patent/NO300973B1/en
Priority to IS3985A priority patent/IS1783B/en
Priority to PT101216A priority patent/PT101216B/en
Priority to AT0048793A priority patent/AT402730B/en
Priority to FI931104A priority patent/FI105098B/en
Priority to HU9300718A priority patent/HU210775B/en
Priority to RU93004833/04A priority patent/RU2109741C1/en
Priority to PL93298037A priority patent/PL170751B1/en
Publication of ES2043535A1 publication Critical patent/ES2043535A1/en
Application granted granted Critical
Publication of ES2043535B1 publication Critical patent/ES2043535B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procedure for producing 1,2,3,9-tetrahydro-9-methyl-3- [(2-methyl-1H-imidazol-1-yl) methyl] -4h-carbazol-4-one of formula i by cyclization the compound of formula ii under conditions of friedel-crafts acylation, by activation of the carboxyl group, catalysed acida, in a solvent medium proper and isolate the product desired by conventional methods. It has properties as an antiemetic in chemotherapy, as well as in treatment of migraine, schizophrenia, anxiety, obesity and mania. (Machine-translation by Google Translate, not legally binding)
ES09200552A 1992-03-13 1992-03-13 PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA. Expired - Fee Related ES2043535B1 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
ES09200552A ES2043535B1 (en) 1992-03-13 1992-03-13 PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA.
SK169-93A SK278786B6 (en) 1992-03-13 1993-03-08 -1h-imidazole-1-yl)methyl|-4h-carbazol-4-one
GR930100094A GR930100094A (en) 1992-03-13 1993-03-09 A process for preparing 1,2,3,9-tetrahydro-9-methyl-3-Ä(2-methyl-1h-imidazol-1-yl)methylÜ-4ii-carbazol-4-one.
CZ93396A CZ281753B6 (en) 1992-03-13 1993-03-10 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-£(2-methyl-1h-imidazol-1-yl)-methyl| -4h-carbazol-4-one
EG14493A EG20262A (en) 1992-03-13 1993-03-10 A process for preparing 1,2,3,9- tetrahydro -9- methyl -3-( 2- metyl -1H-imidazol -1- YL) methyl) -4H- carbazol -4- one
PT101216A PT101216B (en) 1992-03-13 1993-03-11 PROCESS FOR THE PREPARATION OF 1,2,3,9-TETRAHYDRO-9-METHYL-3 - {(2-METHYL-1H-IMIDAZOL-1-YL) METHYL} -4H-CARBAZOLE-4-ONES
NO930887A NO300973B1 (en) 1992-03-13 1993-03-11 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3- [2- (2-methyl-1H-imidazol-1-yl) methyl] -4H-carbazol-4-one
IS3985A IS1783B (en) 1992-03-13 1993-03-11 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3 - [(2-methyl-1H-imidazol-1-yl) methyl] -4H-carbazol-4-one
KR1019930003609A KR100277414B1 (en) 1992-03-13 1993-03-11 Method for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl) methyl] -4H-carbazol-4-one
AR93324474A AR248019A1 (en) 1992-03-13 1993-03-11 Procedure for obtaining 1, 2, 3, 9-tetra hydro-9-methyl-3- ((2-methyl-1h-imidazole-1-il)methyl)-4 h-carbazole-4-on a.
FI931104A FI105098B (en) 1992-03-13 1993-03-12 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3 - [(2-methyl-1H-imidazol-1-yl) methyl] -4H-carbazol-4-one
HU9300718A HU210775B (en) 1992-03-13 1993-03-12 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl-4h-carbazol-4-one
RU93004833/04A RU2109741C1 (en) 1992-03-13 1993-03-12 Method of preparing 1,2,3,9-tetrahydro-9-methyl-3-(2- methyl-1h-imidazol-1-yl)-methyl-4h-carbazol-4-one of formula i
PL93298037A PL170751B1 (en) 1992-03-13 1993-03-12 Method of obtaining 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazoil-1)methyl]-4h-carbazolone-4
AT0048793A AT402730B (en) 1992-03-13 1993-03-12 Process for the preparation of 1,2,3,9-tetrahydro-9- methyl-3-((2-methyl-1h-imidazol-1-yl)methyl)-4h-carbazol- 4-one

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09200552A ES2043535B1 (en) 1992-03-13 1992-03-13 PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA.

Publications (2)

Publication Number Publication Date
ES2043535A1 true ES2043535A1 (en) 1993-12-16
ES2043535B1 ES2043535B1 (en) 1994-08-01

Family

ID=8276385

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09200552A Expired - Fee Related ES2043535B1 (en) 1992-03-13 1992-03-13 PROCEDURE FOR OBTAINING 1,2,3,9-TETRAHYDRO-9-METHYL-3- (2-METHYL-1H-IMIDAZOL-1-IL) METHYL * -4H-CARBAZOL-4-ONA.

Country Status (15)

Country Link
KR (1) KR100277414B1 (en)
AR (1) AR248019A1 (en)
AT (1) AT402730B (en)
CZ (1) CZ281753B6 (en)
EG (1) EG20262A (en)
ES (1) ES2043535B1 (en)
FI (1) FI105098B (en)
GR (1) GR930100094A (en)
HU (1) HU210775B (en)
IS (1) IS1783B (en)
NO (1) NO300973B1 (en)
PL (1) PL170751B1 (en)
PT (1) PT101216B (en)
RU (1) RU2109741C1 (en)
SK (1) SK278786B6 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100368895B1 (en) * 2000-03-30 2003-01-24 하나제약 주식회사 A process for preparing 1,2,3,9-tetrahydro-9-methyl-3- [(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8801247A1 (en) * 1984-01-25 1987-12-16 Glaxo Group Ltd 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives
GB2192885A (en) * 1986-07-23 1988-01-27 Glaxo Group Ltd Heterocyclic compounds
US4725615A (en) * 1985-07-24 1988-02-16 Glaxo Group Limited Carbazole derivatives and their use as 5HT-induced antagonists
ES2000935A6 (en) * 1985-07-24 1988-04-01 Glaxo Group Ltd Process for the preparation of 3-imidazolylmethyltetrahydrocarbazolones.
ES2000936A6 (en) * 1985-07-24 1988-04-01 Glaxo Group Ltd Process for the preparation of 3-imidazolylmethyltetrahydrocarbazolones.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8801247A1 (en) * 1984-01-25 1987-12-16 Glaxo Group Ltd 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives
US4725615A (en) * 1985-07-24 1988-02-16 Glaxo Group Limited Carbazole derivatives and their use as 5HT-induced antagonists
ES2000935A6 (en) * 1985-07-24 1988-04-01 Glaxo Group Ltd Process for the preparation of 3-imidazolylmethyltetrahydrocarbazolones.
ES2000936A6 (en) * 1985-07-24 1988-04-01 Glaxo Group Ltd Process for the preparation of 3-imidazolylmethyltetrahydrocarbazolones.
GB2192885A (en) * 1986-07-23 1988-01-27 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
NO300973B1 (en) 1997-08-25
HUT64537A (en) 1994-01-28
SK278786B6 (en) 1998-02-04
CZ39693A3 (en) 1994-01-19
GR930100094A (en) 1993-11-30
KR100277414B1 (en) 2001-01-15
KR930019665A (en) 1993-10-18
FI931104A (en) 1993-09-14
PL298037A1 (en) 1993-12-27
NO930887D0 (en) 1993-03-11
SK16993A3 (en) 1993-11-10
PT101216B (en) 1999-10-29
EG20262A (en) 1998-05-31
IS1783B (en) 2001-10-22
ES2043535B1 (en) 1994-08-01
FI931104A0 (en) 1993-03-12
PT101216A (en) 1994-03-31
IS3985A (en) 1993-09-14
FI105098B (en) 2000-06-15
CZ281753B6 (en) 1997-01-15
HU210775B (en) 1995-07-28
ATA48793A (en) 1996-12-15
HU9300718D0 (en) 1993-05-28
PL170751B1 (en) 1997-01-31
RU2109741C1 (en) 1998-04-27
AT402730B (en) 1997-08-25
NO930887L (en) 1993-09-14
AR248019A1 (en) 1995-05-31

Similar Documents

Publication Publication Date Title
KR950011407A (en) Tricyclic 1-aminoethylpyrrole derivative
DZ2043A1 (en) New derivatives.
EA199900953A1 (en) SUBSTITUTED PYRAZOLES AS AN INHIBITORS p38 KINASE
IL150757A0 (en) 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
EP0747353A3 (en) Indole derivatives
EP0639567A4 (en) Indole derivative.
FR2642759B1 (en) PYRIMIDYL-PIPERAZINYL-ALKYL AZOLES DERIVATIVES WITH ANXIOLYTIC AND / OR TRANQUILIZING ACTIVITY
RU1799379C (en) Method of substituted indole, benzofuran or benzothiophene derivatives synthesis
DE69323667D1 (en) 4-substituted 1,2,4-triazole derivatives
ES2043535A1 (en) Procedure for the obtaining of 1,2,3,9-tetrahydro-9-methyl-3- (2-methyl-1H-imidazol-1-il) methyl-4h-carbazol-4-ona. (Machine-translation by Google Translate, not legally binding)
PL328323A1 (en) Novel indolic and indazolic compounds, method of obtaining them and pharmaceutic preparations containing such compounds
UA26893C2 (en) METHOD OF OBTAINING ADHESETROXY AND ITS PHARMACEUTICALLY ACCEPTED SALTS
EP0429360A3 (en) Inhibition of withdrawal syndrome
Black et al. Reaction of some 4, 6-dimethoxyindoles with oxalyl chloride
AR007970A1 (en) SUBSTITUTED PYRROLES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM
ATE337781T1 (en) PYRIDINALYKL-AMINOALKYL-1H-INDOLE DERIVATIVES WITH AN INHIBITING EFFECT ON 5-HT AND SEROTONIN REUPPOST AS ANTIDEPRESSANTS AND ANXIOLYTICS
NZ331187A (en) Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
GR3018920T3 (en) Pyrrolidine dione derivatives
Dumitrascu et al. New 1-amidosulphonyl-phenoxyacetyl-3-methyl-pyrazolin-5-one derivatives
ES2070772A1 (en) Acylaminoindole derivatives
ES432441A1 (en) Quinolone derivatives
DE3942991A1 (en) New 2,3-bis:indolyl-maleimide derivs.
ES2070087A1 (en) Indole derivatives
MX9802988A (en) 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them.
GEP20022799B (en) ) Intermediates for Making HIV-Protease Inhibitors and Methods of Making HIV- Protease Inhibitors

Legal Events

Date Code Title Description
GC2A Exploitation certificate registered application with search report

Effective date: 19980113

PC2A Transfer of patent
GC2A Exploitation certificate registered application with search report

Effective date: 20030305

PC2A Transfer of patent
PC2A Transfer of patent
PC2A Transfer of patent

Owner name: WARNER CHILCOTT IBERIA, S.L.

Effective date: 20120411

FD2A Announcement of lapse in spain

Effective date: 20141120